Mattiuzzi, C. & Lippi, G. Worldwide asthma epidemiology: Insights from the Global Health Data Exchange database. Int. Forum. Allergy Rhinol. 10(1), 7580 (2020).
Article Google Scholar
Global Initiative for Asthma (2022) Global Initiative for Asthma (GINA) guidelines. Global strategy for asthma management and prevention (Update 2022). Available from: https://ginasthma.org/gina-reports/ Accessed 07 June 2022.
Mulgirigama, A. et al. A review of the burden and management of mild asthma in adultsImplications for clinical practice. Respir. Med. 152, 97104 (2019).
Article Google Scholar
Duffy, D. L., Martin, N. G., Battistutta, D., Hopper, J. L. & Mathews, J. D. Genetics of asthma and hay fever in Australian twins. Am. Rev. Respir. Dis. 142(6 Pt 1), 13511358 (1990).
CAS Article Google Scholar
Edfors-Lubs, M. L. Allergy in 7000 twin pairs. Acta Allergol. 26(4), 249285 (1971).
CAS Article Google Scholar
Bonnelykke, K. & Ober, C. Leveraging gene-environment interactions and endotypes for asthma gene discovery. J. Allergy Clin. Immunol. 137(3), 667679 (2016).
PubMed Central Article Google Scholar
Temesi, G. et al. Novel genes in human asthma based on a mouse model of allergic airway inflammation and human investigations. Allergy Asthma Immunol. Res. 6(6), 496503 (2014).
CAS PubMed Central Article Google Scholar
Hsiao, W. Y. et al. Association of polymorphisms in DNA repair gene XRCC3 with asthma in Taiwan. In Vivo 32(5), 10391043 (2018).
CAS PubMed Central Article Google Scholar
Chen, L. H. et al. Significant association of MMP2 promoter genotypes to asthma susceptibility in Taiwan. In Vivo 34(6), 31813186 (2020).
CAS PubMed Central Article Google Scholar
Li, C. H. et al. Significant association of Cyclin D1 promoter genotypes with asthma susceptibility in Taiwan. In Vivo 35(4), 20412046 (2021).
CAS PubMed Central Article Google Scholar
Liu, T. et al. Association between Interleukin-4-590C>T polymorphism and the susceptibility to asthma: A meta-analysis of case-control study. J. Healthc. Eng. 2022, 1712715 (2022).
PubMed Central Google Scholar
Shen, T. C. et al. Association of interleukin-12A rs568408 with susceptibility to asthma in Taiwan. Sci. Rep. 7(1), 3199 (2017).
ADS PubMed Central Article Google Scholar
Hsia, T. C. et al. The contribution of interleukin-10 promoter genotypes to susceptibility to asthma in adults. In Vivo 29(6), 695699 (2015).
CAS Google Scholar
Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight?. Nat. Rev. Genet. 9(2), 102114 (2008).
CAS Article Google Scholar
Hu, Y. et al. MicroRNA sequence polymorphisms and the risk of different types of cancer. Sci. Rep. 4, 3648 (2014).
PubMed Central Article Google Scholar
Esquela-Kerscher, A. & Slack, F. J. OncomirsmicroRNAs with a role in cancer. Nat Rev Cancer. 6(4), 259269 (2006).
CAS Article Google Scholar
Wang, M. et al. Plasma miRNAs might be promising biomarkers of chronic obstructive pulmonary disease. Clin. Respir. J. 10(1), 104111 (2016).
CAS Article Google Scholar
Fry, R. C. et al. Air toxics and epigenetic effects: ozone altered microRNAs in the sputum of human subjects. Am. J. Physiol. Lung Cell Mol. Physiol. 306(12), L1129L1137 (2014).
CAS PubMed Central Article Google Scholar
Collison, A., Mattes, J., Plank, M. & Foster, P. S. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J. Allergy Clin. Immunol. 128(1), 1607.e4 (2011).
CAS Article Google Scholar
Liu, Y. et al. Effects of miRNA-145 on airway smooth muscle cells function. Mol. Cell Biochem. 409(12), 135143 (2015).
CAS Article Google Scholar
Li, L. et al. Association between polymorphisms in the promoter region of miR-143/145 and risk of colorectal cancer. Hum. Immunol. 74(8), 993997 (2013).
CAS Article Google Scholar
Yin, X. et al. Rs4705342 polymorphism is involved in the tumorigenesis of HBV positive HCC by altering the binding affinity of HBV induced NF-kB with the promoter region of microRNA-143. J. Cell Biochem. 119(7), 52335242 (2018).
CAS Article Google Scholar
Chu, H. et al. A functional variant in miR-143 promoter contributes to prostate cancer risk. Arch. Toxicol. 90(2), 403414 (2016).
CAS Article Google Scholar
Liang, Y. et al. A functional polymorphism in the promoter of MiR-143/145 is associated with the risk of cervical squamous cell carcinoma in Chinese women: A case-control study. Medicine (Baltimore) 94(31), e1289 (2015).
CAS Article Google Scholar
Yuan, F. et al. A functional variant rs353292 in the flanking region of miR-143/145 contributes to the risk of colorectal cancer. Sci. Rep. 6, 30195 (2016).
ADS CAS PubMed Central Article Google Scholar
Kotarac, N., Dobrijevic, Z., Matijasevic, S., Savic-Pavicevic, D. & Brajuskovic, G. Analysis of association of potentially functional genetic variants within genes encoding miR-34b/c, miR-378 and miR-143/145 with prostate cancer in Serbian population. EXCLI J. 18, 515529 (2019).
PubMed Central Google Scholar
Tiwari, A. et al. COPD-associated miR-145-5p is downregulated in early-decline FEV 1 trajectories in childhood asthma. J. Allergy Clin. Immunol. 147(6), 21812190 (2021).
CAS Article Google Scholar
Yang, M. D. et al. Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan. Biomedicine (Taipei). 7(2), 10 (2017).
PubMed Central Article Google Scholar
Liao, C. H. et al. The role of genotype/phenotype at apurinic/apyrimidinic endonuclease Rs1130409 in renal cell carcinoma. Chin. J. Physiol. 63(1), 4349 (2020).
CAS Article Google Scholar
Huang, C. Y. et al. The contribution of interleukin-8 genotypes and expression to nasopharyngeal cancer susceptibility in Taiwan. Medicine (Baltimore) 97(36), e12135 (2018).
CAS PubMed Central Article Google Scholar
Lee, H. P. et al. Soya-cerebroside reduces interleukin production in human rheumatoid arthritis synovial fibroblasts by inhibiting the ERK, NF-kappa B and AP-1 signalling pathways. Food Hydrocolloids 31(1), 740750 (2020).
CAS Google Scholar
Qiu, Y. Y., Zhang, Y. W., Qian, X. F. & Bian, T. miR-371, miR-138, miR-544, miR-145, and miR-214 could modulate Th1/Th2 balance in asthma through the combinatorial regulation of Runx3. Am. J. Transl. Res. 9(7), 31843199 (2017).
CAS PubMed Central Google Scholar
Fan, L. et al. MicroRNA-145 influences the balance of Th1/Th2 via regulating RUNX3 in asthma patients. Exp. Lung Res. 42(810), 417424 (2016).
CAS Article Google Scholar
Xiong, T., Du, Y., Fu, Z. & Geng, G. MicroRNA-145-5p promotes asthma pathogenesis by inhibiting kinesin family member 3A expression in mouse airway epithelial cells. J. Int. Med. Res. 47(7), 33073319 (2019).
CAS PubMed Central Article Google Scholar
Kano, M. et al. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int. J. Cancer. 127(12), 28042814 (2010).
CAS Article Google Scholar
Chiyomaru, T. et al. miR-145 and miR-133a function as tumor suppressors and directly regulate FSCN1 expression in bladder cancer. Br. J. Cancer. 102(5), 883891 (2010).
CAS PubMed Central Article Google Scholar
Yoshino, H. et al. Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma. Cancer Sci. 104(12), 15671574 (2013).
CAS PubMed Central Article Google Scholar
Kojima, S. et al. The tumor-suppressive microRNA-143/145 cluster inhibites cell migration and invasion by targeting GOLM1 in prostate cancer. J. Hum. Genet. 59(2), 7887 (2014).
CAS Article Google Scholar
Sachdeva, M. & Mo, Y. Y. miR-145-mediated suppression of cell growth, invasion and metastasis. Am. J. Transl. Res. 2(2), 170180 (2010).
CAS PubMed Central Google Scholar
Kent, O. A., McCall, M. N., Cornish, T. C. & Halushka, M. K. Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucleic Acids Res. 42(12), 75287538 (2014).
CAS PubMed Central Article Google Scholar
Harati-Sadegh, M., Sargazi, S., Saravani, M., Sheervalilou, R. & Saravani, M. S. Relationship between miR-143/145 cluster variations and cancer risk: Proof from a meta-analysis. Nucleosides Nucleotides Nucleic Acids 40(5), 578591 (2021).
CAS Article Google Scholar
Kurki, M. I., Karjalainen, J., Palta, P., Sipil, T. P., Kristiansson, K., & Donner, K., et al. FinnGen: Unique genetic insights from combining isolated population and national health register data. medRxiv. 2022:2022.03.03.22271360.
Moffatt, M. F., Gut, I. G., Demenais, F., Strachan, D. P. & Bouzigon, E. A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 363(13), 12111221 (2010).
CAS PubMed Central Article Google Scholar
- CRISPR: A game-changing genetic engineering technique - January 4th, 2023
- Genetic Counseling Online Course - School of Medicine Columbia ... - January 4th, 2023
- Genetics & Medicine - Site Guide - NCBI - National Center for ... - December 27th, 2022
- Lilly, ProQR to expand genetic medicine development agreement - December 27th, 2022
- Central Dogma and Genetic Medicine - HHMI BioInteractive - November 24th, 2022
- Social, Environmental, Cognitive, and Genetic Influences on the Use of ... - November 24th, 2022
- Genetically modified food controversies - Wikipedia - October 29th, 2022
- BSGM - The British Society for Genetic Medicine - October 13th, 2022
- Genetic and Genomic Medicine - Nationwide Children's Hospital - October 13th, 2022
- Carrier Screening for Genetic Conditions | ACOG - October 13th, 2022
- New NHS genetic testing service could save thousands of children in England - The Guardian - October 13th, 2022
- Vertex, after setbacks, moves forward with second-generation rare disease drug - BioPharma Dive - October 13th, 2022
- Passage Bio Announces Appointment of William Chou, M.D. as Chief Executive Officer - Yahoo Finance - October 13th, 2022
- Metagenomi Announces Participation in October Investor and Industry Conferences - Business Wire - October 4th, 2022
- NovaSeq X machines will make genetic analysis even faster and cheaper - Mezha.Media - October 4th, 2022
- ORYZON to Give Updates on Corporate Progress in October - BioSpace - October 4th, 2022
- e-therapeutics: Fundraise of 13.5 million - BioSpace - October 4th, 2022
- The inheritance of hope curing genetic heart disease now within grasp - British Heart Foundation - October 4th, 2022
- MS Genetic Counseling | Ohio State College of Medicine - September 16th, 2022
- Genetic Counselor - Mayo Clinic College of Medicine & Science - September 16th, 2022
- UCLA researcher awarded National Academy of Medicine prize for work on genetics of autism - Newswise - September 16th, 2022
- Medical research doesn't serve everyone. This effort hopes to build one of the most diverse health databases ever - Colorado Public Radio - September 16th, 2022
- Precision Medicine Offers Hope for More Targeted Rash Diagnosis and Treatment - Dermatology Times - September 16th, 2022
- Redmond firefighters to 'Fill the Boot' for Muscular Dystrophy Association - KTVZ - September 16th, 2022
- Why Monkeypox Wasnt Another COVID-19 - FiveThirtyEight - September 16th, 2022
- Endometriosis Researchers One Step Closer to Diagnosing Condition With Menstrual Blood - Business Wire - September 16th, 2022
- The Biggest CGT Breakthroughs Through the Eyes of Our 2022 Power List - The Medicine Maker - September 16th, 2022
- Humans evolved with their microbiomes like genes, your gut microbes pass from one generation to the next - The Conversation - September 16th, 2022
- When to Use Targeted Therapy for Iodine-Refractory Thyroid Cancer - Targeted Oncology - September 16th, 2022
- Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences - PR Newswire - September 16th, 2022
- CRISPR is 10: A decade of gene editing refinements presents new ways to address agricultural diseases thought to be incurable - Genetic Literacy... - September 16th, 2022
- Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for ... - The Bakersfield Californian - September 8th, 2022
- 'Record' Gains in Bringing Research Closer to the Patient - Applied Clinical Trials Online - September 8th, 2022
- Metagenomi Announces Participation in September Investor and Industry Conferences - Business Wire - September 8th, 2022
- Sarepta Therapeutics Announces That FDA has Lifted its Clinical Hold on SRP-5051 for the Treatment of Duchenne Muscular Dystrophy - Yahoo Finance - September 8th, 2022
- Studies Reveal Aggressive Prostate Cancer Linked to Ancestral Heritage - DocWire News - September 8th, 2022
- Lonza and Touchlight collaboration will expands customer's access to DNA - Labiotech.eu - September 8th, 2022
- Elderly are more affected by COVID brain fog, but 'cognitive rehab' could be an effective treatment - Genetic Literacy Project - September 8th, 2022
- A therapy found to improve cognitive function in patients with Down syndrome - EurekAlert - September 8th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 30th, 2022
- Morris Animal Foundation Golden Retriever Lifetime Study Celebrates 10 Years - PR Newswire - August 30th, 2022
- Immortal jellyfish genes identified that may explain their long lives - New Scientist - August 30th, 2022
- Walk Again Or Stop Blindness. How Gene Therapy Is Revolutionizing Medicine - Nation World News - August 30th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 30th, 2022
- Therapeutic Effects of Tretinoin | JIR - Dove Medical Press - August 30th, 2022
- Physical Activity May Have a Stronger Role than Genes in Longevity - Newswise - August 30th, 2022
- BridgeBio, Baylor College of Medicine to Collaborate on Genetic Disease ... - August 22nd, 2022
- New $2.8-million gene therapy becomes most expensive medicine in history - New Atlas - August 22nd, 2022
- Molecular Map Reveals Insights Into the Genetic Drivers of CLL - The ASCO Post - August 22nd, 2022
- Biopharmaceutical Company Expands Clinical Trials On Texas A&M-Developed Angelman Syndrome Treatment - Texas A&M University Today - August 22nd, 2022
- Restrictive abortion laws are limiting the options parents have after receiving genetic test results, experts say - Yahoo News - August 22nd, 2022
- Marketing and Industry Trends Influencing Precision Medicine in 2022 - Healthcare Tech Outlook - August 22nd, 2022
- expert reaction to study investigating use of genetic risk score for prostate cancer in men with lower urinary tract symptoms to predict diagnosis -... - August 22nd, 2022
- As the Smithsonian wraps a genome exhibit, leaders in the field reflect - STAT - August 22nd, 2022
- Why some people suffer more from COVID-19 than others - EurekAlert - August 22nd, 2022
- Q3 2022 Earnings Forecast for LogicBio Therapeutics, Inc. Issued By William Blair (NASDAQ:LOGC) - Defense World - August 22nd, 2022
- Next generation patient avatars: Expanding the possibilities with MicroOrganospheres - EurekAlert - August 22nd, 2022
- Masters Program in Genetic Counseling - Perelman School of Medicine at ... - August 14th, 2022
- Admissions | Master's Program in Human Genetics & Genetic Counseling ... - August 14th, 2022
- The Silver Lining Of Innovation in Genetic Medicine - Pharmaceutical Executive - August 14th, 2022
- Genetics Team Serves as Go-to for Mom of Son With Extremely Rare Disorder - Stanford Medicine Children's Health Blog - Stanford Children's Health - August 14th, 2022
- UI professor receives grant from National Institutes of Health - Iowa Now - August 14th, 2022
- Lilly's Taltz (ixekizumab) Now Available in New, Citrate-Free Formulation to Reduce Injection Site Pain for Improved Patient Experience - PR Newswire - August 14th, 2022
- Research Roundup: 21 Genes Linked to Increased Risk of Alzheimer's and More - BioSpace - August 14th, 2022
- Personalised medicine made in hospitals can revolutionise the way diseases are treated the challenge now will be implementing it - The Conversation... - August 14th, 2022
- Beyond Paxlovid for covid-19: The hunt for better covid medications - Grid - August 14th, 2022
- PVM to Play Role in Research on New Patent-pending Method to Mass-produce Antitumor Cells to Treat Blood Diseases and Cancer - Purdue University - August 14th, 2022
- Analyzing Kiromic BioPharma (NASDAQ:KRBP) and LogicBio Therapeutics (NASDAQ:LOGC) - Defense World - August 14th, 2022
- Corporate America's Abortion Radicalism - The American Conservative - August 14th, 2022
- A team of Oxford and Mexican researchers want to diversify genomic databases. Can they end 'parachute science,' too? - STAT - August 14th, 2022
- The aging heart accumulates mutations while losing the ability to repair them - EurekAlert - August 14th, 2022
- Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results - GuruFocus.com - August 5th, 2022
- Population Genetic Testing: Save Lives And Money, While Avoiding Financial Toxicity - Forbes - August 5th, 2022
- Genetic Counselors Scramble Post- Roe to Provide Routine Pregnancy Services without Being Accused of a Crime - Scientific American - August 5th, 2022
- GENERATION BIO CO. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - Marketscreener.com - August 5th, 2022
- Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results - Yahoo Finance - August 5th, 2022
- Researchers discover one of the largest known bacteria-to-animal gene transfer inside a fruit fly - EurekAlert - August 5th, 2022
- Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress - Yahoo Finance - August 5th, 2022
- Medical Student's Crime In Cipolletti: They Found A Man's DNA Under The Victim's Thumb - Nation World News - August 5th, 2022
- A new era: After winding path and safety scares, gene therapy enters the clinic - Sydney Morning Herald - August 5th, 2022